UnitedHealth Group (UNH-1.67%) is all those things. However, it's also now a big loser. Shares of UnitedHealth Group have plunged more than 50% below the peak achieved late last year.

UnitedHealth Group (NYSE: UNH) is all those things. However, it's also now a big loser. Shares of UnitedHealth Group have plunged more than 50% below the peak achieved late last year.

Professional Analyst Ratings for UnitedHealth Group In the last month, 5 experts released ratings on this stock with an average target price of $364.2. Unusual Options Activity Detected: Smart ...

UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make it a compelling buy-and-hold. Read more here.

Few stocks have been as resilient as UnitedHealth Group (NYSE: UNH). A few weeks ago, UnitedHealth Group was projecting full-year net earnings based on generally accepted accounting principles ...

Midday on Thursday, UnitedHealth Group's stock price had fallen more than 13%. Since a bad quarterly report, the company has seen its stock price fall by more than half, going from nearly $600 per ...

Shares of UnitedHealth Group plunged more than 13% following a report that the Department of Justice is carrying out a criminal investigation into the health-care giant over possible Medicare fraud.

Midday on Thursday, UnitedHealth Group's stock price had fallen more than 13%. Since a bad quarterly report, the company has seen its stock price fall by more than half, going from nearly $600 per ...

The stock price of UnitedHealth Group (NYSE: UNH) is sinking yet again this morning after reports that the private healthcare company is now under criminal investigation by the Department of ...

UnitedHealth Group is being investigated for possible Medicare fraud, according to The Wall Street Journal, sending shares of the healthcare company sliding in after-hours trading just one day ...

UnitedHealth Group announced Tuesday that CEO Andrew Witty is stepping down for personal reasons as the company grapples with unexpectedly high medical costs and withdraws its full-year financial ...